Compound Edaravone Injection for Acute Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Compound Edaravone Injection

DRUG

Edaravone Injection

Trial Locations (28)

100048

Navy General Hospital of The Chinese PLA, Beijing

100050

Beijing Tiantan Hospital affiliated to Capital Medical University, Beijing

100191

Peking University Third Hospital, Beijing

110016

The General Hospital of Shenyang Military, Chinese PLA, Shenyang

150001

The Second Affiliated Hospital of Haerbin Medical University, Haerbin

200003

Shanghai Changzheng Hospital, Shanghai

200025

Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

210006

Nanjing First Hospital, Nanjing

210011

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

210029

Nanjing Brain Hospital, Nanjing

221006

The Affiliated Hospital of Xuzhou Medical College, Xuzhou

250012

Qilu Hospital of Shandong University, Jinan

250033

The Second Hospital of Shandong University, Jinan

266011

Qingdao Municipal Hospital, Qingdao

300000

Tianjin People's Hospital, Tianjin

300052

Tianjin Medical University General Hospital, Tianjin

300060

Tianjin Huanhu Hospital, Tianjin

330006

Jiangxi Provincial People's Hospital, Nanchang

400010

The First Affiliated Hospital of Chongqing Medical University, Chongqing

400038

The First Affiliated Hospital of Third Military Medical University of Chinese PLA, Chongqing

410005

Hunan Provincial People's Hospital, Changsha

510080

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

518036

Peking University Shenzhen Hospital, Shenzhen

050000

The Second Hospital of Hebei Medical University, Shijiazhuang

050051

Hebei General Hospital, Shijiazhuang

014040

Central Hospital of Baotou, Baotou

030001

The First Affiliated Hospital of Shanxi Medical University, Taiyuan

The Second Affiliated Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY

NCT01929096 - Compound Edaravone Injection for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter